DePuy Synthes commenced U.S. launch of TFNA Augmentation, which the company claims is the first PMMA cement system with specific trauma device indications.
DePuy Synthes is launching MAXFRAMEâ„¢, a 3D simulation assisted external circular fixation device for the treatment of limb deformity in the arm, leg, foot or ankle.Â
Orthocell appointed Surgical Specialties as exclusive distributor in Australia and New Zealand for Ortho-ATI® and Ortho-ACI® cell therapies for tendon and cartilage regeneration.Â
OrthAlign received Australian Therapeutic Goods Administration approval of DAA HipAlign® for Direct Anterior Approach Total Hip procedures and UniAlign® for Partial Knee Arthroplasty.